Restructuring and Other Items

3 Months Ended

Mar. 31, 2013

Restructuring and Other Items [Abstract]

Restructuring and other items consisted of:



	Three Months Ended March 31,
($ in millions)	2013			2012
Restructuring and related charges:
Impairments and asset write-offs	$	—		$	0.2
Other restructuring charges	—			0.2
Total restructuring and related charges	—			0.4
Development income	(0.3		)	—
Acquisition-related contingencies	—			0.2
Foreign exchange and other	0.5			(0.8		)
Total restructuring and other items	$	0.2		$	(0.2	)

Restructuring and Related Charges

Total restructuring and related charges incurred during the three months ended March 31, 2012 were associated with the restructuring plan announced in December 2010 (the "2010 plan"). These charges consisted of costs associated with the 2011 closure of a plant in the United States, the reduction of operations at a manufacturing facility in England and the elimination of certain operational and administrative functions at other locations. We do not expect to incur any future charges related to this plan.

The following table presents activity related to our restructuring obligations:



($ in millions)	Severance and benefits
Balance, December 31, 2012	$	2.8
Cash payments	(1.5		)
Balance, March 31, 2013	$	1.3

We expect all payments to be completed by the end of 2013.

Other Items

During the three months ended March 31, 2013, we recorded development income attributable to a Delivery Systems’ customer.

During the three months ended March 31, 2012, we increased the liability for contingent consideration related to our 2010 acquisition of technology used in our SmartDose™ electronic patch injector system (“SmartDose contingent consideration”) by $0.2 million, due to fair value adjustments. The change in our SmartDose contingent consideration during the three months ended March 31, 2013 was immaterial.